Compier Social Media

Home / Innovation / Compier Social Media

Monitor AE’s or PC’s reporting via Social Media Platforms

According to GVP Module VI, all the market authorization holders should regularly monitor the social media platforms and report the potential adverse events generated from different forums.

Our technology platform enables you to capture the relevant data from the uncontrolled and non-regulated platforms of the social media, digitalize and automate the process in compliance with the regulatory requirements.

Compier Social Media Monitoring

Compier’s Social Media Monitoring module enables a pharma company to automate the capture of Adverse events and Product complaints reported via social media platforms such as Twitter, Facebook, Youtube, Medschat with its inbuilt API.

It allows user to capture detailed information about the post and the associated followup information with prebuilt workflows. Prebuilt integration with safety system helps you completely streamline the intake process. Inbuilt KPI based dashboards offer a better insight and compliance on the complete process.

Key Product Features

PV Literature Screening
  • Captures the posts and comments from different official and non-official pages of social media platforms.
  • Captures Adverse Events or Product complaints and transmits the valid AE or PC to the integrated systems.
  • Coherent integration with the safety database (Oracle Argus or ArisG) or Product Quality Complaint Systems for further process.
  • Digitalize the existing spreadsheets with quality and compliance driven system
  • System generated alerts and notifications to meet the timelines for transmitting and processing the records
  • Product specific view of the trending platform for reporting AE’s or PC’s which helps MAH to focus more on monitoring the platform.

How Do we Deliver

Compier Social Media Monitoring is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us